- Jul 30, 2007
- 8,340
- 64
- 0
- School/Org
- Newsbot U
- City
- Barre
- State
- VT
Resverlogix Corp.: First Ever Therapy Targets Optic Nerve Head for Glaucoma (Marketwire via Yahoo! Finance)
Published: Mon, 10 Sep 2007 13:30:00 GMT
Resverlogix Corp. is pleased to announce positive results from preliminary proof-of-concept studies for Resverlogix's TGF-Beta Shield as a potential new therapy for the treatment of glaucoma.
Read More...
Published: Mon, 10 Sep 2007 13:30:00 GMT
Resverlogix Corp. is pleased to announce positive results from preliminary proof-of-concept studies for Resverlogix's TGF-Beta Shield as a potential new therapy for the treatment of glaucoma.
Read More...
